No description available.

Novel therapies and delivery methods directed against malignancies such as melanoma, and particularly metastatic melanoma, are needed. The HIV-1 accessory protein Vpr (viral protein R) has previously been demonstrated to induce G2 cell cycle arrest as well as in vitro growth inhibition/killing of numerous tumor cell lines. In vivo electroporation has been utilized as an effective delivery method for pharmacologic agents as well as DNA plasmids that express "therapeutic" proteins and has been targeted to various tissues including malignant tumors. In this study, we assessed the ability of electroporation-mediated delivery of Vpr plasmid (pVpr) to induce growth attenuation or complete tumor regression in C57BL/6 mice with subcutaneous B16.F10 melanoma lesions. To assess the administration of intratumoral delivery of pVpr with in vivo electroporation, a range of Vpr plasmid dosages, electroporation parameters, and treatment days were evaluated in a subcutaneous B16 murine melanoma model. pVpr was injected directly into the tumors. Immediately following the injection, the subcutaneous tumors were electroporated. Treatment with 25 microgram or 100 microgram of pVpr plus electroporation on days 0 and 4 resulted in complete tumor regressions with long-term survival in 14.3% and 7.1% of the mice, respectively. In order to optimize the treatment regimen, B16 tumors were treated on days 0, 2, and 4 with 100 microgram pVpr plus electroporation which resulted in 50% of the mice with complete tumor regressions and long-term survival. Additional investigations revealed intratumoral Vpr expression and demonstrated that apoptosis was the mechanism by which Vpr caused tumor regression in vivo. This study confirmed that treatment with 100 microgram of pVpr plus electroporation led to durable complete regressions in established murine melanoma lesions. The pVpr plus electroporation treatment regimen has induced complete regressions in mice as well as resistance to tumor challenge in some of the animals. This is the first comprehensive study demonstrating the ability of Vpr, when delivered as a DNA expression plasmid with in vivo electroporation, to induce complete tumor regressions coupled with long- term survival of mice in a highly aggressive and metastatic solid tumor model.

京都大学 / 0048 / 新制・課程博士 / 博士(薬科学) / 甲第18221号 / 薬科博第25号 / 新制||薬科||4(附属図書館) / 31079 / 京都大学大学院薬学研究科医薬創成情報科学専攻 / (主査)教授 掛谷 秀昭, 教授 高須 清誠, 准教授 大野 浩章 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DFAM

京都大学 / 0048 / 新制・課程博士 / 博士(薬科学) / 甲第20312号 / 薬科博第81号 / 新制||薬科||9(附属図書館) / 京都大学大学院薬学研究科医薬創成情報科学専攻 / (主査)教授 大野 浩章, 教授 高須 清誠, 教授 竹本 佳司 / 学位規則第4条第1項該当 / Doctor of Pharmaceutical Sciences / Kyoto University / DFAM

No description available.

No description available.

No description available.

Este trabalho teve como foco a preparação de compostos orgânicos de selênio, fundamentado em plataformas estruturais de moléculas pequenas que pudessem ter suas preparações viabilizadas em reduzido número de etapas, a partir de matérias primas comerciais ou de fácil preparação e economicamente viáveis. O trabalho ficou dividido em 3 partes, sendo que na primeira, optou-se por preparar compostos fundamentados em estruturas derivadas dos ácidos acético, propiônico e butírico. As estratégias de preparação ficaram centradas na geração de HSeNa ou Se2Na2, por reação de selênio e borohidreto de sódio em água ou etanol. As espécies nucleofílicas foram então submetidas a reação com cloro-acetato de sódio ou de etila, levando aos correspondentes diorgano-selenetos ou disselenetos. Também foram preparados derivados de ácido propiônico, α-hidroxilados. Para isso duas abordagens foram empregadas, sendo que em uma mantivemos a estratégia de substituição nucleofílica de um haleto terminal por reação com MeSeLi, levando ao β-metilseleno-α-hidroxipropóide. Na outra, optamos por fazer reacão de abertura de um epóxido glicídico. Neste caso observamos mistura de regioisômeros quando MeSeLi foi empregado. Quando o Grignard correspondente foi usado na reação de abertura do epoxido além de mistura de regioisômeros, também se observou como produto majoritário, o monoseleneto dimérico (provavelmente oriundo de uma de-metilação). Por fim, empregou-se também abertura da γ-butirolactona com disselenolato de sódio, levando ao disselenodi-ácido correspondente. Esses compostos foram submetidos a ensaios preliminares de atividade antioxidante. Destes, o seleno-diacetato de etila apresentou alta seletividade para reação com HOCl, mesmo frente a outras espécies oxidantes e em experimento in vitro com células Hela-60. Além disso foi preparado um seleno-diglicosídeo, também empregando hidrogenoselenolato de sódio, gerado in situ à partir de selênio elementar e borohidreto de sódio. Esse composto foi submetido a ensaios de atividade anticâncer, em associação com β-glucana, levando a ótimos resultados para os experimentos envolvendo câncer de mama e pulmão. Cabe mencionar que nesse caso foram feitos experimentos in vivo com ratos, acrescendo o derivado seleno-açucar e glucana, à dieta dos animais. Por último, foram investigadas estratégias de preparação de sais de Bunte (tiossulfatos orgânicos) de diferentes padrões de substituição. Nessa parte do estudo, tivemos como propósito investigar alguns fatores de reatividade desses compostos frente a espécies nucleofílicas e eletrofílicas de selênio e telúrio, a fim de preparar seleno- e telurosulfetos. Esses por sua vez devem ser submetidos a ensaios biológicos variados. Das estratégias investigadas observamos uma serie de subprodutos das reações envolvendo os sais de Bunte com espécies nucleofílicas de selênio, sendo o que o produto principal foi formado apenas em baixo rendimento e alguns derivados se mostraram bastante instáveis. Em contrapartida, reação bastante seletiva e bons rendimentos foram observados para os casos em que o sal de Bunte agiu como nucleófilo em reações com cátions de selênio e telúrio, gerados por clivagem do dicalcogeneto por persufato de amônio em solvente protônico. Alguns exemplos dos dicalcogenetos puderam ser preparados e caracterizados. / This work was devoted to the preparation of organic selenides, based on structural platforms of small molecules taking in account scalable synthetic procedures in a small steps numbers, from commercial raw materials or from easily prepared and economically viable starting materials. The work was divided into 3 parts, and in the first, it was decided to prepare compounds based on structures derived from acetic, propionic and butyric acids. The preparation strategies were centered on the generation of HSeNa or Na2Se2, by reaction of elemental selenium and sodium borohydride in water or ethanol. The nucleophylic species were then subjected to reaction with sodium chloroacetate, leading to the corresponding diorgano-selenides or disselenides. They were also prepared from α-hydroxylated propionic acid derivatives. For this purpose, two approaches were employed, and in one we maintained the nucleophylic substitution strategy of a terminal halide by reaction with MeSeLi, leading to β-methylseleno-α- hydroxy-propoide. In the other, we chose to perform an epoxi-glycidic opening reaction. In this case, we observed a mixture of regioisomers when MeSeLi was employed. When the corresponding seleno-Grignard was used in the epoxide opening reaction besides a mixture of regioisomers, it was also observed as a major product, the symmetric monoselenide (probably originated from a de-methylation reaction). Finally, it was also used the γ-butyrolactone opening reaction with sodium disselenolate, leading to the corresponding disseleno-diacid. These compounds were submitted to preliminary assays of antioxidant activity. The ethyl Seleno-diacetate showed high selectivity for reaction with HOCl, even in the presence of other oxidant species and in an in vitro experiment with Hela-60 cells. In addition, a Selene-diglycoside was prepared, also employing sodium hydrogen selenide, generated, in situ from elemental selenium and sodium borohydride. It was subjected to anticancer activity assays, in association with β-glucan, leading to great results for experiments involving breast and lung cancer. It is worth mentioning that inthis case experiments were made in vivo with rats, adding our seleno-sugar/glucan system to the diet of the animals. Finally, strategies for the preparation of Bunte salts (organic thiosulphates) of different substitution patterns were investigated. In this part of the study, we intend to investigate some factors of reactivity of these compounds through nucleophilic and electrophilic selenium and tellurium species, in order to prepare seleno- and telluro-sulfides. Opportunely, these compounds should be submitted to biological assays. Under the investigated reaction conditions, we observed a series of by-products of reactions involving the Bunte salts with nucleophilic selenium species, and the main product was formed only in low yield and some derivatives showed to be quite unstable. On the other hand, a fairly selective reaction and good yields were observed for cases in which the Bunte salt was used as the nucleophile in reactions with selenium and tellurium cations, generated by the cleavage of the dichalcogenide by ammonium peroxysulphate in protonic solvent. Some examples of dichalcogenides were prepared and characterized.